Nukkleus (NASDAQ:DFNS) Announces Earnings Results

by · The Cerbat Gem

Nukkleus (NASDAQ:DFNS – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.14) earnings per share for the quarter, Zacks reports.

Nukkleus Stock Up 0.8%

Shares of DFNS traded up $0.00 during mid-day trading on Wednesday, hitting $0.37. 1,753,673 shares of the company’s stock traded hands, compared to its average volume of 2,209,703. The business’s 50-day moving average price is $0.71 and its 200-day moving average price is $2.84. Nukkleus has a 1 year low of $0.33 and a 1 year high of $26.21. The firm has a market capitalization of $13.87 million, a P/E ratio of 0.02 and a beta of -5.98.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Wall Street Zen cut Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday, April 18th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Nukkleus in a research report on Monday, March 23rd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Nukkleus has a consensus rating of “Sell”.

View Our Latest Report on Nukkleus

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in DFNS. GM Advisory Group LLC purchased a new stake in Nukkleus in the fourth quarter worth $56,000. BNP Paribas Financial Markets purchased a new position in Nukkleus during the second quarter valued at $56,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Nukkleus in the 4th quarter worth about $57,000. Millennium Management LLC purchased a new position in Nukkleus during the 4th quarter valued at about $60,000. Finally, State Street Corp increased its stake in shares of Nukkleus by 70.7% during the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after purchasing an additional 7,400 shares in the last quarter. Institutional investors own 12.47% of the company’s stock.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Read More